- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有184家主力机构披露2025-06-30报告期持股数据，持仓量总计4.19亿股，占流通A股47.11%
- 波段诊断：
-
技术面诊股
诊断结果：7.3技术面打败了74%的股票
技术面评分前10的股票
近期的平均成本为20.35元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为20.35元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"20.35","date":1758012152,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，跑赢行业平均水平。
[{"date":"2025.09.17","stock":"-0.15","trade":"-0.79","ind":"0.37"},{"date":"2025.09.16","stock":"1.25","trade":"1.18","ind":"0.04"},{"date":"2025.09.15","stock":"5.26","trade":"1.00","ind":"-0.26"},{"date":"2025.09.12","stock":"1.77","trade":"1.42","ind":"-0.12"},{"date":"2025.09.11","stock":"-1.68","trade":"-0.05","ind":"1.65"},{"date":"2025.09.10","stock":"0.90","trade":"1.48","ind":"0.13"},{"date":"2025.09.09","stock":"-2.54","trade":"-2.41","ind":"-0.51"},{"date":"2025.09.08","stock":"1.95","trade":"1.77","ind":"0.38"},{"date":"2025.09.05","stock":"5.22","trade":"2.36","ind":"1.24"},{"date":"2025.09.04","stock":"-3.60","trade":"-1.63","ind":"-1.25"},{"date":"2025.09.03","stock":"0.21","trade":"-0.22","ind":"-1.16"},{"date":"2025.09.02","stock":"-1.52","trade":"-2.00","ind":"-0.45"},{"date":"2025.09.01","stock":"5.75","trade":"2.46","ind":"0.46"},{"date":"2025.08.29","stock":"2.43","trade":"1.94","ind":"0.37"},{"date":"2025.08.28","stock":"-1.06","trade":"-0.23","ind":"1.14"},{"date":"2025.08.27","stock":"-3.20","trade":"-2.37","ind":"-1.76"},{"date":"2025.08.26","stock":"-2.23","trade":"-2.26","ind":"-0.39"},{"date":"2025.08.25","stock":"2.44","trade":"2.72","ind":"1.51"},{"date":"2025.08.22","stock":"-0.11","trade":"0.42","ind":"1.45"},{"date":"2025.08.21","stock":"-0.86","trade":"0.08","ind":"0.13"},{"date":"2025.08.20","stock":"-1.06","trade":"-0.66","ind":"1.04"}]
九洲药业,上证指数,医疗服务指数
压力支撑
该股压力位为20.28元，支撑位为19.84元。
[{"text":"\u538b\u529b\u4f4d","value":"20.28","date":1758038400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.84","date":1758038400,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：7.1资金面打败了96%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体无进出。
更新时间：09月17日 20:31
| 机构今日流向(万元) | -3273.01 | 机构5日流向(万元) | -1604.43 |
| 机构10日流向(万元) | -8809.80 | 机构20日流向(万元) | -19613.71 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少3512.32万股，其中基金净减仓3家，主力净增仓12家，暂未发现中长期投资价值。
截止2025-06-30，共184家主力机构（基金180家，一般法人3家，社保基金1家），持仓量总计41902.76万股，占流通A股47.11%
其中，基金持仓与2024-12-31相比：
增仓：23家 ，增持 90.12万股
减仓：26家 ，减持 1355.02万股
新出现在主力名单中：116家 ，持有3666.39万股
从主力名单中消失：104家 ，原持有5913.81万股
其中，基金持仓与2024-12-31相比：
增仓：23家 ，增持 90.12万股
减仓：26家 ，减持 1355.02万股
新出现在主力名单中：116家 ，持有3666.39万股
从主力名单中消失：104家 ，原持有5913.81万股
消息面诊股
诊断结果：5.9消息面打败了68%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 九洲药业：9月16日获融资买入1.05亿元，占当日
2025-09-17 - 九洲药业：9月15日获融资买入1.61亿元，占当日
2025-09-16 - 九洲药业：公司始终聚焦主业，通过股份回购、现金分红
2025-09-15 - 九洲药业：9月12日获融资买入1.22亿元，占当日
2025-09-13 - 行业周报|医疗服务指数涨2.16%, 跑赢上证指数
2025-09-12 - 九洲药业：9月11日获融资买入8323.31万元
2025-09-12 - 九洲药业：9月10日获融资买入7009.71万元，
2025-09-11 - 创新药概念股反复活跃，昭衍新药涨停
2025-09-10 - 九洲药业：9月9日获融资买入7618.26万元
2025-09-10 - XD九洲药：9月8日获融资买入1.10亿元，占当日
2025-09-09
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-30 |
| 利好 | 分红转增 | 10派2元(含税) | 2025-08-06 |
| 一般消息 | 募资投向 | 2025-08-06 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-25 |
| 利好 | 分红转增 | 10派3元(含税) | 2025-04-11 |
| 一般消息 | 高管变动 | 因个人原因 | 2024-12-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：4.0行业面打败了53%的股票
医疗服务行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2025.09.17","price":"0.37","value":"-0.79"},{"date":"2025.09.16","price":"0.04","value":"1.18"},{"date":"2025.09.15","price":"-0.26","value":"1.00"},{"date":"2025.09.12","price":"-0.12","value":"1.42"},{"date":"2025.09.11","price":"1.65","value":"-0.05"},{"date":"2025.09.10","price":"0.13","value":"1.48"},{"date":"2025.09.09","price":"-0.51","value":"-2.41"},{"date":"2025.09.08","price":"0.38","value":"1.77"},{"date":"2025.09.05","price":"1.24","value":"2.36"},{"date":"2025.09.04","price":"-1.25","value":"-1.63"},{"date":"2025.09.03","price":"-1.16","value":"-0.22"},{"date":"2025.09.02","price":"-0.45","value":"-2.00"},{"date":"2025.09.01","price":"0.46","value":"2.46"},{"date":"2025.08.29","price":"0.37","value":"1.94"},{"date":"2025.08.28","price":"1.14","value":"-0.23"},{"date":"2025.08.27","price":"-1.76","value":"-2.37"},{"date":"2025.08.26","price":"-0.39","value":"-2.26"},{"date":"2025.08.25","price":"1.51","value":"2.72"},{"date":"2025.08.22","price":"1.45","value":"0.42"},{"date":"2025.08.21","price":"0.13","value":"0.08"},{"date":"2025.08.20","price":"1.04","value":"-0.66"}]
上证指数,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 皓元医药 | 36.77% | 7.54% | 6.8分 |
| 2 | 昭衍新药 | 29.74% | 14.00% | 6.0分 |
| 3 | 普蕊斯 | 29.15% | -1.41% | 6.1分 |
| 4 | 美迪西 | 22.42% | 0.12% | 5.9分 |
| 5 | 毕得医药 | 20.55% | 7.39% | 5.7分 |
| 6 | 博腾股份 | 20.49% | 7.62% | 5.4分 |
| 8 | 康龙化成 | 18.74% | 7.87% | 6.0分 |
| 10 | 成都先导 | 15.10% | 2.27% | 5.5分 |
| 12 | 盈康生命 | 13.87% | -7.84% | 5.6分 |
| 14 | 凯莱英 | 10.70% | 5.15% | 5.6分 |
| 16 | 九洲药业 | 10.01% | 6.47% | 6.7分 |
| 18 | 新里程 | 9.21% | 14.22% | 6.5分 |
| 20 | 皓宸医疗 | 8.59% | 9.69% | 5.6分 |
| 22 | 药康生物 | 6.01% | 0.53% | 7.0分 |
| 24 | 华厦眼科 | 3.29% | 3.24% | 5.8分 |
| 26 | 迪安诊断 | 2.75% | -1.35% | 5.1分 |
| 28 | 睿智医药 | 0.83% | 1.82% | 5.3分 |
| 30 | 通策医疗 | 0.24% | -1.04% | 5.8分 |
| 32 | 和元生物 | -2.23% | 1.41% | 5.8分 |
| 34 | 奥浦迈 | -2.37% | 0.65% | 5.8分 |
| 36 | 爱尔眼科 | -2.72% | 1.02% | 6.0分 |
| 38 | 三博脑科 | -3.34% | 3.56% | 5.5分 |
| 40 | 万邦医药 | -3.71% | 1.63% | 5.1分 |
| 42 | 泓博医药 | -4.80% | 3.12% | 5.7分 |
| 44 | 国际医学 | -6.23% | 0.00% | 5.5分 |
| 46 | 何氏眼科 | -7.80% | 0.93% | 4.6分 |
| 48 | 美年健康 | -10.39% | -0.38% | 5.1分 |
| 50 | 金凯生科 | -11.17% | 0.23% | 4.7分 |
| 52 | 海特生物 | -26.88% | -3.83% | 4.1分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 6/101 ， 25/101。
[{"date":"2025-06-30","value":"6.10","vol":"2.23"},{"date":"2025-03-31","value":"2.89","vol":"0.92"},{"date":"2024-12-31","value":"7.13","vol":"-0.15"},{"date":"2024-09-30","value":"7.42","vol":"3.24"},{"date":"2024-06-30","value":"5.64","vol":"2.52"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
6.10 | 2.89 | 7.13 | 7.42 | 5.64 |
| 行业(%) | 2.23 | 0.92 | -0.15 | 3.24 | 2.52 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"37.45","vol":"36.06"},{"date":"2025-03-31","value":"37.42","vol":"34.67"},{"date":"2024-12-31","value":"33.78","vol":"34.77"},{"date":"2024-09-30","value":"34.75","vol":"36.16"},{"date":"2024-06-30","value":"35.21","vol":"36.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
37.45 | 37.42 | 33.78 | 34.75 | 35.21 |
| 行业(%) | 36.06 | 34.67 | 34.77 | 36.16 | 36.37 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 25/101 ， 22/101。
[{"date":"2025-06-30","value":"3.86","vol":"2.42"},{"date":"2025-03-31","value":"0.98","vol":"-0.08"},{"date":"2024-12-31","value":"-6.57","vol":"-0.73"},{"date":"2024-09-30","value":"-13.36","vol":"0.87"},{"date":"2024-06-30","value":"-15.07","vol":"0.65"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
3.86 | 0.98 | -6.57 | -13.36 | -15.07 |
| 行业(%) | 2.42 | -0.08 | -0.73 | 0.87 | 0.65 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"10.70","vol":"-71.46"},{"date":"2025-03-31","value":"5.68","vol":"-25.93"},{"date":"2024-12-31","value":"-41.34","vol":"-96.53"},{"date":"2024-09-30","value":"-34.74","vol":"-161.08"},{"date":"2024-06-30","value":"-23.62","vol":"-107.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
10.70 | 5.68 | -41.34 | -34.74 | -23.62 |
| 行业(%) | -71.46 | -25.93 | -96.53 | -161.08 | -107.95 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 13/101 ， 42/101。
[{"date":"2025-06-30","value":"0.26","vol":"0.20"},{"date":"2025-03-31","value":"0.13","vol":"0.10"},{"date":"2024-12-31","value":"0.47","vol":"0.41"},{"date":"2024-09-30","value":"0.36","vol":"0.31"},{"date":"2024-06-30","value":"0.25","vol":"0.20"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.26 | 0.13 | 0.47 | 0.36 | 0.25 |
| 行业(次) | 0.20 | 0.10 | 0.41 | 0.31 | 0.20 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.02","vol":"7.41"},{"date":"2025-03-31","value":"0.52","vol":"3.76"},{"date":"2024-12-31","value":"1.76","vol":"16.35"},{"date":"2024-09-30","value":"1.32","vol":"14.25"},{"date":"2024-06-30","value":"0.94","vol":"8.86"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.02 | 0.52 | 1.76 | 1.32 | 0.94 |
| 行业(次) | 7.41 | 3.76 | 16.35 | 14.25 | 8.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/101 ， 40/101。
[{"date":"2025-06-30","value":"40.52","vol":"15.87"},{"date":"2025-03-31","value":"19.17","vol":"-1.69"},{"date":"2024-12-31","value":"28.25","vol":"22.34"},{"date":"2024-09-30","value":"27.85","vol":"12.23"},{"date":"2024-06-30","value":"35.39","vol":"9.92"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 40.52 | 19.17 | 28.25 | 27.85 | 35.39 |
| 行业 | 15.87 | -1.69 | 22.34 | 12.23 | 9.92 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.36","vol":"0.94"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.15","vol":"1.31"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"2.39","vol":"1.44"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.36 | - | 2.15 | - | 2.39 |
| 行业 | 0.94 | 0.00 | 1.31 | 0.00 | 1.44 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 26/101 ， 31/101。
[{"date":"2025-06-30","value":"3.05","vol":"3.69"},{"date":"2025-03-31","value":"3.16","vol":"3.84"},{"date":"2024-12-31","value":"2.97","vol":"3.70"},{"date":"2024-09-30","value":"3.65","vol":"4.11"},{"date":"2024-06-30","value":"3.31","vol":"4.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.05 | 3.16 | 2.97 | 3.65 | 3.31 |
| 行业 | 3.69 | 3.84 | 3.70 | 4.11 | 4.14 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.15","vol":"2.98"},{"date":"2025-03-31","value":"2.22","vol":"3.12"},{"date":"2024-12-31","value":"1.96","vol":"3.01"},{"date":"2024-09-30","value":"2.37","vol":"3.38"},{"date":"2024-06-30","value":"2.27","vol":"3.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.15 | 2.22 | 1.96 | 2.37 | 2.27 |
| 行业 | 2.98 | 3.12 | 3.01 | 3.38 | 3.39 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 36/101 ， 38/101。
[{"date":"2025-06-30","value":"19.86","vol":"32.65"},{"date":"2025-03-31","value":"19.62","vol":"32.24"},{"date":"2024-12-31","value":"22.63","vol":"32.31"},{"date":"2024-09-30","value":"21.67","vol":"31.03"},{"date":"2024-06-30","value":"23.86","vol":"31.65"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
19.86 | 19.62 | 22.63 | 21.67 | 23.86 |
| 行业(%) | 32.65 | 32.24 | 32.31 | 31.03 | 31.65 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.25","vol":"0.95"},{"date":"2025-03-31","value":"0.25","vol":"0.98"},{"date":"2024-12-31","value":"0.29","vol":"1.01"},{"date":"2024-09-30","value":"0.28","vol":"0.85"},{"date":"2024-06-30","value":"0.32","vol":"0.87"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.25 | 0.25 | 0.29 | 0.28 | 0.32 |
| 行业(%) | 0.95 | 0.98 | 1.01 | 0.85 | 0.87 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 长城国瑞证券 | 2025-08-12 | 买入 | |
| 西部证券 | 2025-08-11 | 买入 | |
| 中信建投证券 | 2025-08-10 | 买入 | |
| 华泰金融(HK) | 2025-08-09 | 买入 | |
| 方正证券 | 2025-08-08 | 增持 | |
| 兴业证券 | 2025-08-07 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"6.34","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"9.21","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"10.33","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"6.06","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"9.22","blueLineValue":"1.03","type":"YC"}]